755
Participants
Start Date
August 31, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Pimecrolimus Cream, 1%
Elidel® (pimecrolimus) Cream
Placebo of Pimecrolimus Cream, 1%
Investigational Site 4, Hot Springs
Investigational Site 22, Little Rock
Investigational Site 20, Anaheim
Investigational Site 13, Fremont
Investigational Site 26, Norco
Investigational Site 17, Doral
Investigational Site 9, Hialeah
Investigational Site 16, Miami
Investigational Site 18, Miami
Investigational Site 19, Miami
Investigational Site 25, Miami
Investigational Site 8, Miami
Investigational Site 12, North Miami Beach
Investigational Site 3, Ormond Beach
Investigational Site 7, South Miami
Investigational Site 10, Tampa
Investigational Site 24, Tampa
Investigational Site 14, West Palm Beach
Investigational Site 1, Arlington Heights
Investigational Site 21, Lake Charles
Investigational Site 2, Silver Spring
Investigational Site 11, Saint Joseph
Investigational Site 27, East Windsor
Investigational Site 5, High Point
Investigational Site 23, Raleigh
Investigational Site 15, Cincinnati
Investigational Site 6, Nashville
Lead Sponsor
Glenmark Pharmaceuticals Ltd. India
INDUSTRY